Results 241 to 250 of about 1,671,061 (305)
This diagram illustrates that MIIP suppresses tumor‐associated neutrophils infiltration and NETs formation by binding to PKR, which impairs the PKR–IKKβ interaction and attenuates NF‐κB/IL‐8 axis activation, thereby inhibiting colorectal cancer progression. This mechanism highlights a promising therapeutic target for CRC patients.
Jiaxin Li +8 more
wiley +1 more source
In Reply: Immune checkpoint inhibition in medulloblastoma: moving toward biologically informed strategies. [PDF]
Viana-Pereira M, Fontão P, Reis RM.
europepmc +1 more source
PLOD1 interacts with ENO1 and limits its FBXW7‐dependent ubiquitination and proteasomal degradation through a mechanism requiring PLOD1 catalytic activity. ENO1 stabilization sustains glycolysis, promoting glioblastoma cell proliferation, migration, and temozolomide resistance.
Fen Xue +4 more
wiley +1 more source
Nurse-coordinated biomarker and symptom monitoring for immune checkpoint inhibitor toxicity. [PDF]
Feng Y, Yuan F, Zhao S.
europepmc +1 more source
Immune checkpoint inhibitor-associated eosinophilic fasciitis: a systematic review of reported cases. [PDF]
Argobi Y, Tobeigei F, Alasiri FI.
europepmc +1 more source
Virological Events During Immune Checkpoint Inhibitor Therapy: A Multi-Source Evaluation. [PDF]
Cao Y +6 more
europepmc +1 more source
Clinical characteristics analysis of immune checkpoint inhibitors-related myocarditis. [PDF]
Wang R, Hao C, Liu J, Zhang Z, Qin S.
europepmc +1 more source
Immune checkpoint inhibitors induced autoimmune hemolytic anemia in patients with malignant cancer. [PDF]
Liang A +11 more
europepmc +1 more source

